BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » Page 173

BIOINFORMANT’S MISSION: To be OMNIPRESENT in the Stem Cell and Cord Blood Marketplace

March 13, 2015 By Cade Hildreth (CEO) Leave a Comment

You Deserve Transparency

Some companies will not share their mission with you. They think it is top-secret information, private to them, something they have to hold under close guard.

This doesn’t make any sense.  We want you to have a clear understanding of our mission, because we want to serve you, partner with you, and most importantly, be fully transparent with you.

Therefore, here is BioInformant’s mission for 2015…

To be OMNIPRESENT in the stem cell and cord blood banking marketplace.

Educating You About the Stem Cell Space
Educating you about stem cell and cord blood markets, so you can make smarter decisions, faster.

[Read more…]

Filed Under: Stem Cells Tagged With: bioinformant, clients, leadership, marketplace, mission, serving, strategy, transparency, trust, values

[Featured on MarketResearch.com] 4 Key Metrics You Need to Know to Invest in the Cord Blood Sector

March 12, 2015 By Cade Hildreth (CEO) Leave a Comment

BioInformant's Cord Blood Market Analytics Featured on MarketResearch.com

MarketResearch.com has posted an article titled, “4 Key Metrics You Need to Know to Invest in the Cord Blood Sector,” featuring BioInformant’s analytics for the cord blood banking market.

An excerpt is included below: 

“If you are an investor considering an opportunity within the cord blood market, the market can initially appear technical and confusing. However, if you focus on four key metrics, you can quickly and easily assess the technical attributes that matter, including market size, market potential, market competition, and market growth rates.”

Hematopoietic Stem Cell Transplant Rates

A trusted business partner of ours, MarketResearch.com has been selected by Inc. 5000 Magazine as one of America’s fastest growing private companies.

View full post → 

Filed Under: Cord Blood, HSCs, MSCs Tagged With: analytics, cord blood, infographic, market research, marketresearch.com, metrics

BioInformant iPS Cell Data Featured on Centre for Commercialization of Regenerative Medicine

March 12, 2015 By Cade Hildreth (CEO) Leave a Comment

iPS Cell Infographics Featured on Centre for Commercialization of Regenerative Medicine Blog

BioInformant is excited to share that our induced pluripotent stem cell industry analytics have been featured on the “Signals Blog,” published by the Centre for Commercialization of Regenerative Medicine (CCRM). CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies.

iPSC Infograhpics Featured on Centre for Commercialization of Regenerative Medicine CCRMThe post, titled Right Turn: Commercializing iPSCs – Infographics, states:  “The beauty of an infographic (or two) is it speaks for itself.”

Induced Pluripotent Stem Cells Infographics

View Full CCRM Post → 

 

Filed Under: iPS Cells, Stem Cells Tagged With: CCRM, featured on, induced pluripotent stem cells, infographics, iPSC, regenerative medicine, stem cells

My Story: President of a Stem Cell Market Research Firm and a Stem Cell Patient

March 12, 2015 By Cade Hildreth (CEO) 1 Comment

Cade Hildreth, Autologous Stem Cell Patient

For the past 15 years, I have studied stem cells, including technology and research advances, as well as market trends. I have been fascinated with them for most of my adult life, founding BioInformant as the first and only market research firm to specialize in the stem cell industry.

As a result of this decision, I have had the honor of serving thousands clients from across the stem cell industry and been interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine.

However, it was only recently that I experienced the power of stem cells to impact my own life and health.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: autologous, cell therapy, regenerative medicine, stem cells

“We’re not made of drugs, we’re made of cells”

March 12, 2015 By Cade Hildreth (CEO) Leave a Comment

We're not made of drugs, we're made of cells.

Below is a short and simple quote that we say often here at BioInformant…

Stem Cell Quote 2

Remember as you make medical decisions in your life that you are not made of drugs, you are made of cells. The source of every cell in your adult body was originally a stem cell.

The importance of stem cells to you and your capacity to a live longer and healthier life cannot be understated.
[Read more…]

Filed Under: Stem Cells Tagged With: cellular therapy, quote, regenerative medicine, stem cells

  • « Previous Page
  • 1
  • …
  • 171
  • 172
  • 173
  • 174
  • 175
  • …
  • 177
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97

Featured Posts

PolarityTE RMAT

PolarityTE Announces FDA RMAT Awarded to Its Designation Granted to SkinTE®

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

What Is An RMAT? List of Publicly Announced RMAT Designations (64)

i-peaces-cell-manufacturing

I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.